BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 29371107)

  • 1. Advance Directive Utilization Is Associated with Less Aggressive End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Cappell K; Sundaram V; Park A; Shiraz P; Gupta R; Jenkins P; Periyakoil VSJ; Muffly L
    Biol Blood Marrow Transplant; 2018 May; 24(5):1035-1040. PubMed ID: 29371107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the Landscape of Advance Care Planning in Adolescents and Young Adults Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A 5-Year Retrospective Review.
    Pennarola BW; Fry A; Prichett L; Beri AE; Shah NN; Wiener L
    Transplant Cell Ther; 2022 Mar; 28(3):164.e1-164.e8. PubMed ID: 34936929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective Randomized Study of Advance Directives in Allogeneic Hematopoietic Cell Transplantation Recipients.
    Tan IT; Sundaram V; Ramirez Y; Burnash S; Kate Tierney D; Muffly LS
    Transplant Cell Ther; 2021 Jul; 27(7):615.e1-615.e7. PubMed ID: 33836311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Salazar MM; DeCook LJ; Butterfield RJ; Zhang N; Sen A; Wu KL; Vanness DJ; Khera N
    J Palliat Med; 2022 Jan; 25(1):97-105. PubMed ID: 34705545
    [No Abstract]   [Full Text] [Related]  

  • 5. Healthcare Utilization is High in Adult Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation.
    Langston JA; Sundaram V; Periyakoil VS; Muffly L
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1659-1665. PubMed ID: 30959162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are written advance directives helpful to guide end-of-life therapy in the intensive care unit? A retrospective matched-cohort study.
    Hartog CS; Peschel I; Schwarzkopf D; Curtis JR; Westermann I; Kabisch B; Pfeifer R; Guenther A; Michalsen A; Reinhart K
    J Crit Care; 2014 Feb; 29(1):128-33. PubMed ID: 24331948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-of-Life Care Intensity in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: A Population-Level Analysis.
    Johnston EE; Muffly L; Alvarez E; Saynina O; Sanders LM; Bhatia S; Chamberlain LJ
    J Clin Oncol; 2018 Oct; 36(30):3023-3030. PubMed ID: 30183467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advance Care Planning and Palliative Care Integration for Patients Undergoing Hematopoietic Stem-Cell Transplantation.
    Wang WS; Ma JD; Nelson SH; Revta C; Buckholz GT; Mulroney CM; Roeland EJ
    J Oncol Pract; 2017 Sep; 13(9):e721-e728. PubMed ID: 28644706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and Impact of Post-Transplant Interdisciplinary Palliative Care Consultation in Older Allogeneic Hematopoietic Cell Transplant Recipients.
    Lin RJ; Cohen AG; Stabler SM; Devlin SM; Elko TA; Maloy MA; Korc-Grodzicki B; Alexander K; Kramer D; Sanchez-Escamilla M; Castillo Flores N; Barker JN; Cho C; Dahi PB; Gyurkocza B; Papadopoulos EB; Perales MA; Politikos I; Ponce DM; Sauter CS; Scordo M; Shaffer BC; Shah GL; Tamari R; Young JW; Jakubowski AA; Giralt SA; Nelson JE
    J Palliat Med; 2020 Dec; 23(12):1653-1657. PubMed ID: 32216649
    [No Abstract]   [Full Text] [Related]  

  • 10. Preliminary report of the integration of a palliative care team into an intensive care unit.
    O'Mahony S; McHenry J; Blank AE; Snow D; Eti Karakas S; Santoro G; Selwyn P; Kvetan V
    Palliat Med; 2010 Mar; 24(2):154-65. PubMed ID: 19825893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The illusion of end-of-life resource savings with advance directives. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.
    Teno J; Lynn J; Connors AF; Wenger N; Phillips RS; Alzola C; Murphy DP; Desbiens N; Knaus WA
    J Am Geriatr Soc; 1997 Apr; 45(4):513-8. PubMed ID: 9100723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research.
    Auletta JJ; Kou J; Chen M; Bolon YT; Broglie L; Bupp C; Christianson D; Cusatis RN; Devine SM; Eapen M; Hamadani M; Hengen M; Lee SJ; Moskop A; Page KM; Pasquini MC; Perez WS; Phelan R; Riches ML; Rizzo JD; Saber W; Spellman SR; Stefanski HE; Steinert P; Tuschl E; Yusuf R; Zhang MJ; Shaw BE
    Transplant Cell Ther; 2023 Jun; 29(6):346.e1-346.e10. PubMed ID: 36924931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The process of advance care planning in HCT candidates and proxies: self-efficacy, locus of control, and anxiety levels.
    Duckworth KE; Forti AM; Russell GB; Naik S; Hurd D; McQuellon RP
    Am J Hosp Palliat Care; 2014 Nov; 31(7):710-6. PubMed ID: 23946253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Advance Directives on End-of-Life Care for Adolescents and Young Adults Undergoing Hematopoietic Stem Cell Transplant.
    Needle J; Smith AR
    J Palliat Med; 2016 Mar; 19(3):300-5. PubMed ID: 26895198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Admission of hematopoietic cell transplantation patients to the intensive care unit at the Pontificia Universidad Católica de Chile Hospital.
    Escobar K; Rojas P; Ernst D; Bertin P; Nervi B; Jara V; Garcia MJ; Ocqueteau M; Sarmiento M; Ramirez P
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):176-9. PubMed ID: 25139214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes-results of a retrospective analysis from a German university hospital.
    Garcia Borrega J; Heger JM; Koehler P; Holtick U; Hallek M; Scheid C; Böll B; Shimabukuro-Vornhagen A; Kochanek M; Eichenauer DA
    Ann Hematol; 2022 Feb; 101(2):389-395. PubMed ID: 34668981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity of End-of-Life Care for Patients with Hematologic Malignancies and the Role of Race/Ethnicity.
    Kirtane K; Downey L; Lee SJ; Curtis JR; Engelberg RA
    J Palliat Med; 2018 Oct; 21(10):1466-1471. PubMed ID: 29975599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advance care planning in patients undergoing hematopoietic cell transplantation.
    Joffe S; Mello MM; Cook EF; Lee SJ
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):65-73. PubMed ID: 17222754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes Toward Advance Directives Among Patients and Their Family Members in China.
    Kang L; Liu XH; Zhang J; Shan PY; Wang JP; Zhong P; Du XH; Du YF; Yu BC; Wei N; Lou HL; Bian O; Chen HH; Lin F; Zhou HL; He W; Long HC; Hong LR; Su H; Yang JN; Jiang YL; Shi Y; Ning J; Liang F; Wang Z; Gong T; Zhu ML; Ning XH; Chen ZJ; Chen LK
    J Am Med Dir Assoc; 2017 Sep; 18(9):808.e7-808.e11. PubMed ID: 28676293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients.
    Heybati K; Ochal D; Hogan W; Al-Khateeb H; Sklar D; Herasevich S; Litzow M; Shah M; Torghabeh MH; Durani U; Bauer P; Gajic O; Yadav H
    Ann Hematol; 2024 Mar; 103(3):957-967. PubMed ID: 38170240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.